Skip to main content
. 2014 Dec 9;2014:808320. doi: 10.1155/2014/808320

Table 2.

Anticoagulation strategies and vascular access for renal replacement therapy.

Anticoagulation strategy, n (%) Vascular access, n (%)
CVVHD_Heparin 3593 (33.8) Femoral vein 4604 (43.3)
Genius_Heparin 3543 (33.3) Right sided jugular vein 2149 (20.2)
CVVHD_Citrate 2956 (27.8) Left sided jugular vein 1663 (15.6)
Genius_Citrate 75 (0.7) Right sided subclavian vein 959 (9.0)
CVVDH_Argatroban 156 (1.5) Left sided subclavian vein 1098 (10.3)
Genius_Argatroban 230 (2.2) Not documented or another vascular access 170 (1.6)
CVVHD_without anticoagulation 90 (0.8)